Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H18F3N3O4S2 |
| Molecular Weight | 401.425 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC1NC2=C(C=C(C(=C2)C(F)(F)F)S(N)(=O)=O)S(=O)(=O)N1
InChI
InChIKey=AKHXXQAIVSMYIS-UHFFFAOYSA-N
InChI=1S/C13H18F3N3O4S2/c1-2-3-4-5-12-18-9-6-8(13(14,15)16)10(24(17,20)21)7-11(9)25(22,23)19-12/h6-7,12,18-19H,2-5H2,1H3,(H2,17,20,21)
| Molecular Formula | C13H18F3N3O4S2 |
| Molecular Weight | 401.425 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://www.genome.jp/dbget-bin/www_bget?D01241Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/3772156
Sources: http://www.genome.jp/dbget-bin/www_bget?D01241
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/3772156
Penflutizide is a thiazide diuretic drug, Na+-Cl- symport inhibitor. Penflutizide was shown to have high potency to photooxidize lipids. Penflutizide -photosensitized peroxidation of squalene was repressed by the presence of sodium azide or 2,5-dimethylfuran and was accelerated in a D2O suspension. These findings suggest the participation of singlet oxygen in Penflutizide photoperoxidation of squalene (type II mechanism). Penflutizide -photosensitized lysis of red blood cells (RBC) accompanied by formation of hydroperoxides in RBC membrane lipids was also noted. These results suggested that membrane lipids can be one of the target molecules of Penflutizide phototoxicity. Penflutizide is an ingredient of the drug Praemenstron manufactured by Nordmark Arzneimittel and consisting of Flumedroxone, Meprobamate, Penflutizide.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Lipid peroxidation Sources: http://www.ncbi.nlm.nih.gov/pubmed/3772156 |
|||
Target ID: CHEMBL1876 Sources: http://www.genome.jp/dbget-bin/www_bget?D01241 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Praemenstron Approved UseCurrently is only licensed as an anxiolytic. |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| UV-A induced DNA nicking activities of skin photosensitive drugs: phenothiazines, benzothiadiazines and afloqualone. | 1988 |
|
| Lipid peroxidative potency of photosensitized thiazide diuretics. | 1986-11 |
|
| Arginine reversion and lambda induction in E. coli with benzothiadiazine diuretics irradiated with near-ultraviolet light. | 1985-12 |
|
| [Therapeutic experiences with Praemenstron in the premenstrual syndrome]. | 1974-03-10 |
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3772156
RBC (1 X 108 cells/ml) were irradiated with UVA (0-108 kJ/ m2) in the
presence of Penflutizide (625 uM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:19:33 GMT 2025
by
admin
on
Mon Mar 31 19:19:33 GMT 2025
|
| Record UNII |
91NGD0O6FZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C49185
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
217-186-6
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
100000082480
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
DTXSID3048815
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107203
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
3398
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
C008781
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
C74409
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
SUB09665MIG
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
96782-78-4
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
SUPERSEDED | |||
|
91NGD0O6FZ
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
55126-39-1
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
SUPERSEDED | |||
|
1766-91-2
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY | |||
|
4726
Created by
admin on Mon Mar 31 19:19:33 GMT 2025 , Edited by admin on Mon Mar 31 19:19:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |